Evaluation of Effect of Exercise on Prescription
Recruitment status was Active, not recruiting
The purpose of this study is to evaluate the effect of a primary healthcare intervention called 'Exercise on Prescription' aimed at increasing level of physical activity in a population of sedentary patients with increased risk of developing lifestyle diseases. The effect is evaluated using both objective and patient-reported variables.
Metabolic Syndrome X
Diabetes Mellitus, Type 2
Behavioral: Exercise on Prescription
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Effect of Exercise on Prescription on Physical Activity, Physical Fitness, and Health in Patients With Lifestyle Diseases|
- Maximal oxygen uptake at 4 and 10 months
- Bodyweight and Body Mass Index at 4 and 10 months
- Glycemic control at 4 and 10 months
- Patient-reported physical activity level at 4 and 10 months
- Patient-reported health related quality of life at 4 and 10 months
- Patient-reported amount and intensity of exercise at 4 and 10 months
- Patient-reported physical fitness at 4 and 10 months
- Patient-reported compliance with national guidelines for physical activity at 4 and 10 months
|Study Start Date:||January 2005|
|Estimated Study Completion Date:||August 2007|
Exercise prescriptions are used for initiating a physical active lifestyle in sedentary populations.
A Danish project called ‘Exercise on Prescription’ (EoP) is implemented in primary healthcare. Patients eligible for EoP are non-institutionalised adults with medically controlled lifestyle diseases or risk factors of lifestyle diseases, who are motivated to change lifestyle, able to improve health status through a physical active lifestyle, and willing to pay a fee of €100 for the intervention.
The purpose of this study is to assess the effect on: 1) maximal oxygen uptake (VO2max), 2) bodyweight and Body Mass Index, 3) glycemic control (in patients with impaired glucose tolerance), 4) physical activity level, and 5) health related quality of life.
The EoP-group is compared to a control group.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00399997
|Centre of Applied and Clinical Exercise Sciences, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark|
|Odense, Denmark, DK-5230|
|Principal Investigator:||Jes Bak Sørensen, MSc||Centre of Applied and Clinical Exercise Sciences, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark|